论文部分内容阅读
目的:总结安列克注射液用于剖宫产术与产后出血预防中的临床效果。方法:筛选2014年11月至2015年11月在恩平市人民医院行剖宫产术分娩的产妇共110例,对其进行分组:治疗组(57例,施以安列克注射液)、常规组(53例,施以缩宫素),对两组产后出血预防临床效果进行对照。结果:治疗后,治疗组产时出血量(220.6±20.45)m L、24 h产后出血量(20.1±10.1)m L、产后出血发生率7.02%均优于常规组产时出血量(270.8±15.59)m L、24 h产后出血量(26.7±16.2)m L、产后出血发生率26.41%,组间比较,差异具有统计学意义(P<0.05)。结论:安列克注射液在剖宫产术与产后出血预防中的应用效果良好,能够减少产妇产后出血量,改善患者病情,且该药的安全性较好。
Objective: To summarize the clinical efficacy of Aileike injection in the prevention of cesarean section and postpartum hemorrhage. Methods: A total of 110 pregnant women delivered by cesarean section at Enping People’s Hospital from November 2014 to November 2015 were selected and divided into two groups: treatment group (57 cases treated with Anilek injection), routine Group (53 cases, administered oxytocin), the clinical effect of prevention of postpartum hemorrhage between the two groups were compared. Results: After treatment, the amount of bleeding in the treatment group was (220.6 ± 20.45) m L, the incidence of postpartum hemorrhage was (20.1 ± 10.1) m L in 24 h and the incidence of postpartum hemorrhage was 7.02% 15.59) m L, the amount of postpartum hemorrhage (26.7 ± 16.2) m L after 24 h and the postpartum hemorrhage rate was 26.41%. There was significant difference between the two groups (P <0.05). Conclusion: The application of Aileike injection in preventing cesarean section and postpartum hemorrhage is effective, which can reduce the amount of postpartum hemorrhage and improve the patient’s condition, and the drug is safe.